B cells are key pathogenic effectors in multiple sclerosis (MS) and several therapies have been designed to restrain B cell abnormalities by directly targeting this lymphocyte population.
Giacomini, E., Rizzo, F., Etna, M.p., Cruciani, M., Mechelli, R., Buscarinu, M.c., et al. (2018). Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients. MULTIPLE SCLEROSIS, 24(2), 127-139 [10.1177/1352458517695892].
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients
Etna, Marilena P;Pica, Francesca;D'Agostini, Cartesio;Severa, Martina
2018-01-01
Abstract
B cells are key pathogenic effectors in multiple sclerosis (MS) and several therapies have been designed to restrain B cell abnormalities by directly targeting this lymphocyte population.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Multiple Sclerosis J 2017.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
810.37 kB
Formato
Adobe PDF
|
810.37 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
